Abbott India Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Abbott India Ltd (ABOT)
Abbott India Ltd stock price live, this page displays NSE ABOT stock exchange data. View the ABOT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Abbott India Ltd real time stock price chart below.
What Is the Abbott India Ltd Stock Price Today?
The Abbott India Ltd stock price today is 26,245.00.
What Is the Stock Symbol for Abbott India Ltd?
The stock symbol for Abbott India Ltd is "ABOT."
What Stock Exchange Does Abbott India Ltd Trade On?
Abbott India Ltd is listed and trades on the NSE stock exchange.
Is Abbott India Ltd a Good Stock to Buy?
Determining whether Abbott India Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ABOT quote. (ISIN: INE358A01014)
What Is the Abbott India Ltd Stock Price Today?
The Abbott India Ltd stock price today is 26,245.00.
What Is the Stock Symbol for Abbott India Ltd?
The stock symbol for Abbott India Ltd is "ABOT."
What Stock Exchange Does Abbott India Ltd Trade On?
Abbott India Ltd is listed and trades on the NSE stock exchange.
Is Abbott India Ltd a Good Stock to Buy?
Determining whether Abbott India Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ABOT quote. (ISIN: INE358A01014)
26,245.00
-480.00(-1.80%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
26,125.00
26,790.00
52 wk Range
25,150.00
35,310.00
ABOT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
26,125.0026,790.00
52 wk Range
25,150.0035,310.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.00%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.00%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ABOT Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high P/E ratio relative to near-term earnings growth
- Abbott India Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Abbott India Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Abbott India Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Abbott India Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Abbott India Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Abbott India Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Abbott India Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Abbott India Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Abbott India Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Earnings
Latest Release
May 11, 2026
EPS / Forecast
185.80 / --
Revenue / Forecast
17.1B / 17.17B
Compare ABOT to Peers and Sector
Metrics to compare | ABOT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipABOTPeersSector | |
|---|---|---|---|---|
P/E Ratio | 35.9x | 31.0x | −0.4x | |
PEG Ratio | 3.76 | 1.51 | 0.00 | |
Price/Book | 11.7x | 6.0x | 2.6x | |
Price / LTM Sales | 8.0x | 5.1x | 3.0x | |
Upside (Analyst Target) | 20.6% | 2.8% | 49.7% | |
Fair Value Upside | Unlock | 2.4% | 7.3% | Unlock |
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women’s health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, neuro-psychiat, pain management, respiratory, hepatic, neuroscience, metabolics, gennext, and consumer care products. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Capital India Limited.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Abbott India (ABOT) Stock Price Today?
The Abbott India stock price today is 26,245.00 INR.
What Stock Exchange Does Abbott India Trade On?
Abbott India is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Abbott India?
The stock symbol for Abbott India is "ABOT."
Does Abbott India Pay Dividends? What’s The Current Dividend Yield?
The Abbott India dividend yield is 2%.
What Is the Abbott India Market Cap?
As of today, Abbott India market cap is 557.43B INR.
What Is Abbott India's Earnings Per Share (TTM)?
The Abbott India EPS (TTM) is 730.36.
When Is the Next Abbott India Earnings Date?
Abbott India will release its next earnings report on Aug 12, 2026.
From a Technical Analysis Perspective, Is ABOT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Abbott India Stock Split?
Abbott India has split 0 times.
How Many Employees Does Abbott India Have?
Abbott India has 3659 employees.
What is the current trading status of Abbott India (ABOT)?
As of Jul 08, 2026, Abbott India (ABOT) is trading at a price of 26,245.00 INR, with a previous close of 26,725.00 INR. The stock has fluctuated within a day range of 26,125.00 INR to 26,790.00 INR, while its 52-week range spans from 25,150.00 INR to 35,310.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.